Literature DB >> 19542928

Cutaneous rosai-dorfman disease and morphea: coincidence or association?

Jeaneen A Chappell1, Nicole M Burkemper, John L Frater, M Yadira Hurley.   

Abstract

Rosai-Dorfman disease or sinus histiocytosis with massive lymphadenopathy is a rare disease. A third of patients with this disease have extranodal involvement affecting the skin. Of these individuals, only around 3% will have purely cutaneous Rosai-Dorfman disease, which is limited to skin manifestations without systemic involvement. Cutaneous (localized) scleroderma or morphea, on the other hand, is a more common disease that most often affects women of all ages. Both conditions have unknown etiologies. Presented here is a case of a 60-year-old white woman with cutaneous Rosai-Dorfman disease and coexisting morphea. Representative biopsies from both areas were performed: one showing a dermal S-100+ histiocytic infiltrate with emperipolesis and the other showing a deep perivascular and interstitial plasma cell infiltrate with dermal sclerosis and loss of perieccrine fat. A laboratory and radiologic workup revealed no evidence of systemic involvement by either entity. The diagnosis of coexisting cutaneous Rosai-Dorfman disease and morphea was established. To our knowledge, this is the first report of these 2 entities found simultaneously in 1 patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542928     DOI: 10.1097/DAD.0b013e318196f883

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report.

Authors:  Joya Hadchiti; Francois G Kamar; Jean Abi Ghosn; Mohamad Haidar; Ahmad Younes; Antoine Obeid; Marwan Haddad; Fadi Farhat; Feras Chehade
Journal:  Mol Clin Oncol       Date:  2017-11-21

2.  Purely cutaneous rosai-dorfman disease with immunohistochemistry.

Authors:  Uzma Farooq; Anna H Chacon; Vladimir Vincek; George W Elgart
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.